Dr. Francis M. Cuss, M.B., B.Chir., FRCP

Independent Director

Francis Cuss is a physician-scientist, with a background in general and academic medicine, who has developed a broad experience in pharmaceutical research, in clinical development and in executive management within globally operating biopharma companies during a career of more than 30 years in the pharmaceutical industry; specifically, with Bristol-Myers Squibb, Schering-Plough and Glaxo.

Francis retired from Bristol-Myers Squibb in July 2017 having served as Executive Vice President, Chief Scientific Officer and head of R&D since July 2013. He is a member of the board of directors of Novo Holdings A/S, Denmark, and Trustee of Montclair State University, NJ USA. He was previously a board director at Rubius Therapeutics, Glympse Bio and Mural Oncology Cambridge MA, Chair of the Board of Trustees at Montclair State University and a member of the Advisory Committee to the Director of the NIH.

Prior to joining the pharmaceutical industry, Francis was a practicing physician with a specialization in pulmonary medicine in the UK. He received his education and medical training in the United Kingdom. He holds medical degrees from Cambridge University, U.K. and is a fellow of the Royal College of Physicians and the Faculty of Pharmaceutical Medicine. He has published numerous articles and book chapters on topics of medical interest and organizational effectiveness.